You just read:

Drug-Treatment Opportunities in Advanced Ovarian Cancer Will be Limited by a Reduced Risk of Disease Recurrence and an Only Modest Increase in Incidence

News provided by

Decision Resources

Dec 08, 2010, 09:15 ET